Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2011 | 330 Thousand USD | -60.43% |
| 2010 | 834 Thousand USD | 59.77% |
| 2009 | 522 Thousand USD | -53.48% |
| 2008 | 1.12 Million USD | 4.37% |
| 2007 | 1.07 Million USD | 51.2% |
| 2006 | 711 Thousand USD | -67.39% |
| 2005 | 2.18 Million USD | 456.12% |
| 2004 | 392 Thousand USD | -89.04% |
| 2003 | 3.57 Million USD | -67.84% |
| 2002 | 11.11 Million USD | 19.75% |
| 2001 | 9.28 Million USD | -1.68% |
| 2000 | 9.44 Million USD | 162.33% |
| 1999 | 3.6 Million USD | 33.33% |
| 1998 | 2.7 Million USD | 0.0% |
| 1997 | 2.7 Million USD | 125.0% |
| 1996 | 1.2 Million USD | 33.33% |
| 1995 | 900 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2011 FY | 330 Thousand USD | -60.43% |
| 2010 FY | 834 Thousand USD | 59.77% |
| 2009 Q1 | 156 Thousand USD | -40.23% |
| 2009 FY | 522 Thousand USD | -53.48% |
| 2008 FY | 1.12 Million USD | 4.37% |
| 2008 Q1 | 406 Thousand USD | 77.29% |
| 2008 Q4 | 261 Thousand USD | 177.66% |
| 2008 Q3 | 94 Thousand USD | -73.82% |
| 2008 Q2 | 359 Thousand USD | -11.58% |
| 2007 FY | 1.07 Million USD | 51.2% |
| 2007 Q4 | 229 Thousand USD | 37.95% |
| 2007 Q2 | 483 Thousand USD | 146.43% |
| 2007 Q1 | 196 Thousand USD | 6433.33% |
| 2007 Q3 | 166 Thousand USD | -65.63% |
| 2006 Q4 | 3000.00 USD | -98.99% |
| 2006 Q2 | 201 Thousand USD | -4.74% |
| 2006 FY | 711 Thousand USD | -67.39% |
| 2006 Q1 | 211 Thousand USD | -80.17% |
| 2006 Q3 | 296 Thousand USD | 47.26% |
| 2005 Q4 | 1.06 Million USD | 197.21% |
| 2005 FY | 2.18 Million USD | 456.12% |
| 2005 Q2 | 418 Thousand USD | 25.15% |
| 2005 Q3 | 358 Thousand USD | -14.35% |
| 2005 Q1 | 334 Thousand USD | 219.29% |
| 2004 FY | 392 Thousand USD | -89.04% |
| 2004 Q4 | -280 Thousand USD | -391.67% |
| 2004 Q3 | 96 Thousand USD | 24.68% |
| 2004 Q2 | 77 Thousand USD | -78.61% |
| 2004 Q1 | 360 Thousand USD | -65.32% |
| 2003 Q1 | 699 Thousand USD | -81.73% |
| 2003 FY | 3.57 Million USD | -67.84% |
| 2003 Q4 | 1.03 Million USD | 403.88% |
| 2003 Q3 | 206 Thousand USD | -87.4% |
| 2003 Q2 | 1.63 Million USD | 133.91% |
| 2002 Q2 | 1.86 Million USD | -9.87% |
| 2002 Q3 | 3.36 Million USD | 80.57% |
| 2002 FY | 11.11 Million USD | 19.75% |
| 2002 Q4 | 3.82 Million USD | 13.7% |
| 2002 Q1 | 2.06 Million USD | -31.08% |
| 2001 Q4 | 2.99 Million USD | 17.47% |
| 2001 FY | 9.28 Million USD | -1.68% |
| 2001 Q3 | 2.55 Million USD | 38.98% |
| 2001 Q2 | 1.83 Million USD | -3.16% |
| 2001 Q1 | 1.89 Million USD | -49.14% |
| 2000 Q4 | 3.73 Million USD | 108.73% |
| 2000 FY | 9.44 Million USD | 162.33% |
| 2000 Q1 | 1.4 Million USD | -17.35% |
| 2000 Q2 | 2.14 Million USD | 52.31% |
| 2000 Q3 | 1.78 Million USD | -16.5% |
| 1999 Q1 | 800 Thousand USD | -33.33% |
| 1999 Q4 | 1.7 Million USD | 54.55% |
| 1999 Q2 | - USD | -100.0% |
| 1999 FY | 3.6 Million USD | 33.33% |
| 1999 Q3 | 1.1 Million USD | 0.0% |
| 1998 FY | 2.7 Million USD | 0.0% |
| 1998 Q4 | 1.2 Million USD | 140.0% |
| 1998 Q3 | 500 Thousand USD | 25.0% |
| 1998 Q2 | 400 Thousand USD | 0.0% |
| 1998 Q1 | 400 Thousand USD | -20.0% |
| 1997 Q1 | 100 Thousand USD | -83.33% |
| 1997 Q4 | 500 Thousand USD | -28.57% |
| 1997 Q3 | 700 Thousand USD | -12.5% |
| 1997 FY | 2.7 Million USD | 125.0% |
| 1997 Q2 | 800 Thousand USD | 700.0% |
| 1996 Q3 | 500 Thousand USD | 150.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 FY | 1.2 Million USD | 33.33% |
| 1996 Q2 | 200 Thousand USD | 100.0% |
| 1996 Q4 | 600 Thousand USD | 20.0% |
| 1995 Q4 | 100 Thousand USD | 107.69% |
| 1995 Q1 | 100 Thousand USD | 0.0% |
| 1995 FY | 900 Thousand USD | 0.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q3 | -1.3 Million USD | -1400.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 71.655% |
| Ansell Limited | 129.3 Million USD | 99.745% |
| Ansell Limited | 129.3 Million USD | 99.745% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 98.94% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 120.681% |
| Psykey, Inc. | -797.5 Thousand USD | 141.379% |
| ConvaTec Group Plc | 262.7 Million USD | 99.874% |
| ConvaTec Group Plc | 262.7 Million USD | 99.874% |
| Encision Inc. | -640.78 Thousand USD | 151.499% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 332.706% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 400.191% |
| Innovative MedTech Inc. | -4.27 Million USD | 107.721% |
| LifePoint, Inc. | -7.49 Million USD | 104.403% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 105.093% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 368.533% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 170.622% |
| SmileDirectClub, Inc. | -241.15 Million USD | 100.137% |
| Sector 10, Inc. | -39.84 Thousand USD | 928.23% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 99.897% |
| SheerVision, Inc. | 155.72 Thousand USD | -111.911% |
| United Health Products, Inc. | -2.42 Million USD | 113.6% |
| Vasamed, Inc. | 4.74 Million USD | 93.041% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 114.384% |
| Yubo International Biotech Limited | -1.2 Million USD | 127.381% |